News

People go bonkers over electrolyte enhanced thirst quenchers for ‘holy hydration’ after gym workouts, party hangovers or ...
Cipla Health Ltd., a leader in fast-moving wellness goods in India, is offering holistic health solutions to manage common ...
Common flu, seasonal throat infections, and fevers are on the rise in India, making it imperative to practice every day self-care and community protection. Leading the charge, Cipla Health Ltd., one ...
With this launch, Cipla Health marks its foray into the fruit juice-based beverage segment. Prolyte ElectroShot builds on the legacy of Prolyte a leader in the oral rehydration category, and ...
Prolyte ElectroShot fits into everyday life, whether at home, at work, or on the move." To ensure wide availability, Cipla Health is rolling out Prolyte ElectroShot through its extensive ...
Cipla Health Ltd., one of India's most trusted fast-moving wellness goods (FMWG) companies, has announced the launch of Prolyte ElectroShot, a ready-to-drink electrolyte based hydration beverage ...
Cipla Health Ltd., one of India's most trusted fast-moving wellness goods (FMWG) companies, has announced the launch of Prolyte ElectroShot, a ready-to-drink electrolyte based hydration beverage.
Cipla Ltd reported a robust 30% YoY increase in consolidated net profit, reaching Rs 1,222 crore for Q4 FY25, driven by strong sales in India, the US, and Africa.
Cipla beats profit estimates with strong demand for chronic condition drugs, faces supply chain issues for tumour drug.
Cipla receives approval to market Afrezza, a rapid-acting insulin inhaler, offering a needle-free solution for diabetes management.
Shivam Puri, CEO, Cipla Health, discusses the brand proposition of Prolyte ORS, shares strategy that helped brand achieve Rs 1,000-crore revenue milestone, and provides insights into the brand's ...
Cipla share price: Cipla Ltd shares fell the most in terms of percentage among all the 50 companies in the NSE Nifty today on Wednesday, October 30, 2024. Cipla share price: Cipla Ltd shares fell ...